Toggle navigation
Home
Search
Services
Blog
Contact
About
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W.
Kadmus Pharmaceuticals, Inc., Irvine, CA, United States
Search 32 grants from Kelvin Gee
Search grants from Kadmus Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Rational Development of Bioengineered Factor IX Variants for Hemophilia B Therapy
Cell Polarity and Cytokinesis
Molecular Analysis Of A Region On 1q Linked With NIDDM
Minority Predoctoral Fellowship Program
Dietary Modulation of Cell Cycle Regulators
Recently added grants:
Characterizing the nuclear pore complex-T cell receptor connection
Antibiotic discovery from environmental microorganisms of Brazil
Developing strategies for effective debridement in patients for venous leg ulcers
Development of selective Pin1 inhibitors to target a common oncogenic mechanism
The Inflammasome as a novel mediator and therapeutic target of GI syndrome
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41MH060527-01A1
Application #
6134497
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Murphy, Diane
Project Start
2000-06-01
Project End
2002-05-31
Budget Start
2000-06-01
Budget End
2002-05-31
Support Year
1
Fiscal Year
2000
Total Cost
$120,208
Indirect Cost
Institution
Name
Kadmus Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Irvine
State
CA
Country
United States
Zip Code
92612
Related projects
NIH 2001
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$7,023
NIH 2000
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$120,208
Comments
Be the first to comment on this grant